WebBackground: Several randomized control trials (RCTs) have showed that adding either abiraterone acetate (AA) or docetaxel (D) to androgen-deprivation therapy (ADT) improves survival of metastatic castration-sensitive prostate cancer patients (mCSPC). Yet, the cost-effectiveness of these treatment options has not been fully compared under Hong Kong's … WebThe cost for abiraterone oral tablet 250 mg is around $146 for a supply of 30 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and …
Abiraterone acetate Drugs BNF NICE
WebJun 23, 2024 · Zytiga contains the drug abiraterone acetate. It’s a type of medication used in hormone therapy, which is a treatment that lowers the level of male hormones in the … WebJun 2, 2024 · Scenario analysis suggested AAP could be cost-effective in M1 patients if priced below £62/day, or below £28/day in the M0 subgroup. AAP could dominate SOC in the M0 subgroup with price below £11/day. AAP is effective for non-metastatic and metastatic disease but is not cost-effective when using the BNF price. flywheel online
Cost-utility analysis of adding abiraterone acetate plus ... - PLOS
WebThis price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. A generic version of Zytiga (abiraterone) is available. See … WebJul 4, 2024 · Fig. 2. Cost-effectiveness acceptability curves for comparing the three strategies (a) by willingness-to-pay threshold and (b) by cost of abiraterone acetate with willingness-to-pay (WTP) threshold at WebMar 17, 2024 · abiraterone acetate Table of contents Overview Authorisation details Product information Assessment history Authorised This medicine is authorised for use in the European Union. Overview Abiraterone Mylan is a cancer medicine used to treat men with metastatic prostate cancer. green river silver company ri